Literature DB >> 2783366

Striatal dysfunction in attention deficit and hyperkinetic disorder.

H C Lou1, L Henriksen, P Bruhn, H Børner, J B Nielsen.   

Abstract

We have previously reported that periventricular structures are hypoperfused in attention deficit and hyperactivity disorder (ADHD). This study has expanded the number of patients, who were divided into two groups: six patients with pure ADHD, and 13 patients with ADHD in combination with other neurologic symptoms. By using xenon 133 inhalation and emission tomography, the regional cerebral blood flow distribution was determined and compared with a control group. Striatal regions were found to be hypoperfused and, by inference, hypofunctional in both groups. This hypoperfusion was statistically significant in the right striatum in ADHD, and in both striatal regions in ADHD with other neuropsychologic and neurologic symptoms. The primary sensory and sensorimotor cortical regions were highly perfused. Methylphenidate increased flow to striatal and posterior periventricular regions, and tended to decrease flow to primary sensory regions. Low striatal activity, partially reversible with methylphenidate, appears to be a cardinal feature in ADHD.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2783366     DOI: 10.1001/archneur.1989.00520370050018

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  51 in total

Review 1.  Neuropsychiatry of the basal ganglia.

Authors:  H A Ring; J Serra-Mestres
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-01       Impact factor: 10.154

Review 2.  The neuropsychopharmacology of action inhibition: cross-species translation of the stop-signal and go/no-go tasks.

Authors:  Dawn M Eagle; Andrea Bari; Trevor W Robbins
Journal:  Psychopharmacology (Berl)       Date:  2008-06-10       Impact factor: 4.530

3.  D2 dopamine receptor subtype-mediated hyperactivity and amphetamine responses in a model of ADHD.

Authors:  Xueliang Fan; Ming Xu; Ellen J Hess
Journal:  Neurobiol Dis       Date:  2009-10-22       Impact factor: 5.996

4.  A pattern of test findings predicting attention problems at school.

Authors:  M Korkman; K Peltomaa
Journal:  J Abnorm Child Psychol       Date:  1991-08

5.  Methylphenidate attenuates rats' preference for a novel spatial stimulus introduced into a familiar environment: assessment using a force-plate actometer.

Authors:  Stephen C Fowler; Troy J Zarcone; Beth Levant
Journal:  J Neurosci Methods       Date:  2010-03-25       Impact factor: 2.390

6.  Regional cerebral blood flow in children with attention deficit hyperactivity disorder: comparison before and after methylphenidate treatment.

Authors:  Jae Sung Lee; Boong Nyun Kim; Eunjoo Kang; Dong Soo Lee; Yu Kyeong Kim; June-Key Chung; Myung Chul Lee; Soo Churl Cho
Journal:  Hum Brain Mapp       Date:  2005-03       Impact factor: 5.038

7.  Neurobehavioral study of borderline personality disorder.

Authors:  R van Reekum; C A Conway; D Gansler; R White; D L Bachman
Journal:  J Psychiatry Neurosci       Date:  1993-05       Impact factor: 6.186

8.  Neurocognitive effects of methylphenidate in adult attention-deficit/hyperactivity disorder.

Authors:  Danielle C Turner; Andrew D Blackwell; Jonathan H Dowson; Andrew McLean; Barbara J Sahakian
Journal:  Psychopharmacology (Berl)       Date:  2004-08-27       Impact factor: 4.530

9.  Selective effects of methylphenidate in attention deficit hyperactivity disorder: a functional magnetic resonance study.

Authors:  C J Vaidya; G Austin; G Kirkorian; H W Ridlehuber; J E Desmond; G H Glover; J D Gabrieli
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-24       Impact factor: 11.205

Review 10.  European consensus statement on diagnosis and treatment of adult ADHD: The European Network Adult ADHD.

Authors:  Sandra J J Kooij; Susanne Bejerot; Andrew Blackwell; Herve Caci; Miquel Casas-Brugué; Pieter J Carpentier; Dan Edvinsson; John Fayyad; Karin Foeken; Michael Fitzgerald; Veronique Gaillac; Ylva Ginsberg; Chantal Henry; Johanna Krause; Michael B Lensing; Iris Manor; Helmut Niederhofer; Carlos Nunes-Filipe; Martin D Ohlmeier; Pierre Oswald; Stefano Pallanti; Artemios Pehlivanidis; Josep A Ramos-Quiroga; Maria Rastam; Doris Ryffel-Rawak; Steven Stes; Philip Asherson
Journal:  BMC Psychiatry       Date:  2010-09-03       Impact factor: 3.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.